EUVIMEDEUVIMED entdecken
Crossref

Coagulation Disorders in Philadelphia Chromosome-negative Myeloproliferative Neoplasms—A Guide for Specialists in Coagulation Disorders

Christina Hart iD, Andreas Tiede, Christina C Rolling, Karolin Trautmann-Grill

Hämostaseologie · 11.06.2026

DOI: 10.1055/a-2882-0640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 11.06.2026. Verfasst von Christina Hart und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Regensburg, Department of Hematology and Oncology, Bavaria, Germany, Regensburg.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) are acquired clonal disorders of hematopoiesis that typically cause thromboembolic and hemorrhagic complications. These include an increased risk of both arterial and venous thromboembolic events as well as a heightened bleeding tendency. Venous thromboembolic events frequently manifest at atypical sites and characteristically present as splanchnic vein thrombosis. A common cause of the elevated bleeding risk is acquired von Willebrand syndrome. Clinical indicators of an underlying MPN include thromboembolic events of unclear etiology or occurring at atypical sites, as well as acquired cutaneous or mucocutaneous bleeding tendencies. A hallmark of MPN in peripheral blood counts is hyperproliferation. Further diagnostic evaluation includes testing for the three major driver mutations (JAK2, CALR, MPL) and bone marrow biopsy. Management of thromboembolic event requires cytoreductive therapy and, depending on the site of thrombosis, antiplatelet therapy, and/or anticoagulation. Our review provides an overview of essential thrombocythemia, polycythemia vera, and primary myelofibrosis, as well as the hemostatic disorders associated with these conditions, focusing on diagnostic approaches and the prophylaxis and management of thromboembolic and bleeding complications.

Autor:innen und Institutionen

  • University Hospital Regensburg, Department of Hematology and Oncology, Bavaria, Germany, Regensburg.
  • Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Lower Saxony, Germany, Hannover.
  • University Medical Center Hamburg-Eppendorf, Oncology, Hematology and Bone Marrow Transplantation with the Section of Pneumology, Hamburg, Germany, Hamburg.
  • Technical University Dresden, Department of Hematology and Oncology, Sachsen, Germany, Dresden.

ORCID-Profile: Christina Hart

Zitieren

APA

Hart, C., Tiede, A., Rolling, C. C., & Trautmann-Grill, K. (2026). Coagulation Disorders in Philadelphia Chromosome-negative Myeloproliferative Neoplasms—A Guide for Specialists in Coagulation Disorders. Hämostaseologie. https://doi.org/10.1055/a-2882-0640

Vancouver

Hart C, Tiede A, Rolling CC, Trautmann-Grill K. Coagulation Disorders in Philadelphia Chromosome-negative Myeloproliferative Neoplasms—A Guide for Specialists in Coagulation Disorders. Hämostaseologie. 2026. doi:10.1055/a-2882-0640

BibTeX
@article{Hart2026,
  author = {Hart, Christina and Tiede, Andreas and Rolling, Christina C and Trautmann-Grill, Karolin},
  title = {Coagulation Disorders in Philadelphia Chromosome-negative Myeloproliferative Neoplasms—A Guide for Specialists in Coagulation Disorders},
  journal = {Hämostaseologie},
  year = {2026},
  doi = {10.1055/a-2882-0640}
}
Kostenlos starten →